Trials / Terminated
TerminatedNCT02951975
Ozurdex® in Patients With Non-infectious Uveitis Affecting the Posterior Segment of the Eye
Multicentre Longitudinal Study of the Prescription of Ozurdex® in Patients With Non-infectious Uveitis Affecting the Posterior Segment of the Eye
- Status
- Terminated
- Phase
- —
- Study type
- Observational
- Enrollment
- 246 (actual)
- Sponsor
- Allergan · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This observational study will evaluate the safety, efficacy, characteristics of patients, characteristics of physicians and quality of life in patients who are prescribed OZURDEX® as treatment for non-infectious uveitis of the posterior segment of the eye in France.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | dexamethasone intravitreal implant | Dexamethasone intravitreal implant (OZURDEX®) as prescribed in clinical practice. |
Timeline
- Start date
- 2017-01-25
- Primary completion
- 2018-11-28
- Completion
- 2018-12-19
- First posted
- 2016-11-01
- Last updated
- 2019-08-02
Locations
21 sites across 1 country: France
Source: ClinicalTrials.gov record NCT02951975. Inclusion in this directory is not an endorsement.